NDRA
ENDRA Life Sciences IncNASDAQHEALTHCAREDIAGNOSTICS & RESEARCH
Key Statistics
Market Cap
$6.41M
P/E Ratio
—
EPS
$-8.65
Beta
-0.22
52W High
$11.96
52W Low
$2.90
50-Day MA
$3.84
200-Day MA
$4.91
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
0.00
About ENDRA Life Sciences Inc
ENDRA Life Sciences Inc. develops technology for clinical diagnostic ultrasound. The company is headquartered in Ann Arbor, Michigan.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-5.72M |
| Operating Margin | 0.00% |
| Return on Equity | -291.60% |
| Return on Assets | -86.70% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.22 |
| Price-to-Book | 2.33 |
| Price-to-Sales (TTM) | 1838.78 |
| EV/Revenue | 1845.91 |
| EV/EBITDA | -0.11 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $1.24M |
| Float | $1.17M |
| % Insiders | 37.34% |
| % Institutions | 15.76% |
Historical Volatility
HV 10-Day
124.00%
HV 20-Day
102.06%
HV 30-Day
92.81%
HV 60-Day
88.04%
HV Rank
—
Volatility is currently expanding
Data last updated: 4/9/2026